-
The amount of new traditional Chinese medicine drugs is imminent, and the industry is optimistic about the traditional Chinese medicine enterprises that gnaw the "hard bones" under the research
Time of Update: 2023-01-01
js?cdnversion='+~(-new Date()/36e5)];In recent years, with the acceleration of the review and approval of innovative Chinese medicine drugs and the implementation of a number of substantial favorable policies for traditional Chinese medicine, China's innovative drug industry has developed rapidly, and the approval of new drugs has been increasing, since 2017, a total of 19 innovative traditional Chinese medicine drugs have been approved, of which 8 products have been approved for marketing in 2021, a record number.
-
Deaths from unexplained kidney disease rose to 178 in Indonesia
Time of Update: 2022-11-15
(End) Indonesian Health Minister Budi Gunadi Sadikin reported in Jakarta on the 2nd that the number of cases of unexplained kidney disease reported in the country has increased to 325, of which 178 deaths.
-
Tens of billions of "unspeakable" market: in pharmacies to sell, gross profit of more than 88%, 171 products in line
Time of Update: 2022-09-21
In 1998, Viagra was born, with sales of more than $1 billion almost every year; In 2000, it was approved for marketing as a prescription drug in China.
-
The main points of the development and reform process of my country's pharmaceutical packaging materials policies, regulations and management
Time of Update: 2022-08-30
On August 4, 2002, "Regulations on the Implementation of the Drug Administration Law of the People's Republic of China"It established a legal basis for the management system of the registration certificate of pharmaceutical packaging materials .
-
In response to market demand, the pharmaceutical equipment industry presents three major trends
Time of Update: 2022-08-15
The industry as a whole presents three trends of integration, automation and intelligence, and is gradually realizing Import substitution of high-end pharmaceutical equipment In this context, some pharmaceutical equipment companies actively respond to market demand, continuously strengthen independent research and development and technological innovation, and improve the manufacturing level and production capacity of equipment.
-
Pesticide residues of fruits and vegetables-no need to smell the "medicine" discoloration
Time of Update: 2022-03-22
Therefore, Strengthening the detection of pesticide residues in vegetables entering the farmer's market, supermarkets and other edible agricultural products trading markets is the key to preventing the fruits and vegetables exceeding the standard pesticide residues from entering the people's table .
-
GlaxoSmithKline first-in-class antibiotics apply for clinical application in China
Time of Update: 2021-12-08
Article source: Medical Rubik's Cube InfoAuthor: Shi BeiOn November 11, the CDE official website showed that the clinical application of GSK's new antibiotic Gepotidacin tablets was accepted by the State Food and Drug Administration .
-
Antibacterial peptide polymer bone cement has made progress in the treatment of chronic osteomyelitis
Time of Update: 2021-11-11
Antibacterial polypeptide polymer bone cement has made progress in the treatment of chronic osteomyelitis Recently, Professor Liu Runhui’s research team from the School of Materials Science and Engineering of East China University of Science and Technology and Professor Lin Haodong’s team from Shanghai First People’s Hospital have prepared PMMA (polymethyl methacrylate) doped with antimicrobial peptide polymers based on host defense peptide simulation.
-
Huibaoyuan Bio's new anti-cancer drug xylazine obtained clinical trial approval from the U.S. FDA
Time of Update: 2021-11-05
This study aims to evaluate the overall survival benefit and safety of JP001 combined with standard radiotherapy and chemotherapy for newly diagnosed GBM patients .
Combined with surgical resection and radiotherapy, the median survival can be extended to 12.
-
The development of the domestic pharmaceutical industry continues to improve, and a large number of talents from multinational pharmaceutical companies are turning to local companies
Time of Update: 2021-11-04
Eid, an expert in the medical field, officially announced that he would join Hengrui Medicine in October as executive vice president, chief medical officer and head of global drug development .
-
Current status of research and development of neuropathic pain drugs
Time of Update: 2021-08-16
Recently, the literature reported that the target KCNQ2/3/5 (Kv7) channel opener retigabine (RTG) can significantly reduce Neuronal excitability, and effective in a variety of pain models, the two-hole potassium channel subtype TREK1 (TWIK-related K+ channel 1) is the key target of morphine analgesia without opioid adverse reactions, which provides new opportunities for neuropathic pain Treatment strategies .
-
Shrink tumors by more than 80% AKT targeted protein degradation therapy is expected to treat a variety of cancers
Time of Update: 2021-07-31
The researchers screened an AKT protein degradation agent called M21 and tested its anti-cancer activity in mouse models of breast and prostate cancer .
▲M21 reduces tumor growth by 90% in a mouse model of prostate cancer (picture source: reference [1])The researchers also evaluated which cancers are sensitive to this protein degrading agent .
-
Winbond Health Methylprednisolone Sodium Succinate for Injection passed the consistency evaluation of generic drugs
Time of Update: 2021-07-06
On June 9th, Winbond Health announced that Winbond Pharmaceuticals, a wholly-owned subsidiary, has recently received the "Notice of Supplementary Application Approval" for methylprednisolone sodium succinate for chemical injections approved and issued by the National Medical Products Administration.
-
News of the adjustment of the list of essential medicines came out
Time of Update: 2021-06-08
comIn September of this year, the three-year basic drug catalogue adjustment may begin, and companies can seize this opportunity to increase the volume of new products.
-
Self Renew column｜Targeted anti-tumor therapy derived from autoimmune diseases—review a 2016 article
Time of Update: 2021-06-05
If antibodies that target extracellular DNA can be used, we have the hope of achieving precise delivery of anti-tumor drug molecules.
In this way, as the treatment progresses, the antigen at the tumor site not only does not decrease, but increases, so as to maintain or even continuously improve the delivery effect of the drug.
